Shandong Xinhua Pharmaceutical Co Ltd (000756) - Total Liabilities

Latest as of June 2025: CN¥3.87 Billion CNY ≈ $566.69 Million USD

Based on the latest financial reports, Shandong Xinhua Pharmaceutical Co Ltd (000756) has total liabilities worth CN¥3.87 Billion CNY (≈ $566.69 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shandong Xinhua Pharmaceutical Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Shandong Xinhua Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shandong Xinhua Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Shandong Xinhua Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shandong Xinhua Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Metalurgica Gerdau S.A SA:GOAU3	Brazil	R$28.08 Billion
JOST Werke AG XETRA:JST	Germany	€1.27 Billion
SG Fleet Group Ltd AU:SGF	Australia	AU$2.91 Billion
Cisen Pharmaceutical Co Ltd SHG:603367	China	CN¥1.29 Billion
LifeSemantics Corp. KQ:347700	Korea	₩408.85 Billion
Fujian Longma Envi Sanitation SHG:603686	China	CN¥3.36 Billion
Kelsian Group Ltd AU:KLS	Australia	AU$1.56 Billion
Center Laboratories TWO:4123	Taiwan	NT$6.17 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Shandong Xinhua Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Xinhua Pharmaceutical Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.76	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Xinhua Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)

The table below shows the annual total liabilities of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥3.80 Billion ≈ $556.37 Million	+8.31%
2023-12-31	CN¥3.51 Billion ≈ $513.68 Million	-10.34%
2022-12-31	CN¥3.92 Billion ≈ $572.92 Million	+6.37%
2021-12-31	CN¥3.68 Billion ≈ $538.63 Million	-0.56%
2020-12-31	CN¥3.70 Billion ≈ $541.67 Million	+11.31%
2019-12-31	CN¥3.33 Billion ≈ $486.62 Million	+6.60%
2018-12-31	CN¥3.12 Billion ≈ $456.50 Million	+15.79%
2017-12-31	CN¥2.69 Billion ≈ $394.25 Million	+1.92%
2016-12-31	CN¥2.64 Billion ≈ $386.82 Million	+5.40%
2015-12-31	CN¥2.51 Billion ≈ $367.01 Million	--

About Shandong Xinhua Pharmaceutical Co Ltd

SHE:000756 China Drug Manufacturers - Specialty & Generic

Market Cap

$865.20 Million

CN¥5.91 Billion CNY

Market Cap Rank

#9720 Global

#2573 in China

Share Price

CN¥11.95

Change (1 day)

-0.50%

52-Week Range

CN¥11.95 - CN¥18.15

All Time High

CN¥44.80